img

Global Buclizine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Buclizine Market Research Report 2024

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.
According to Mr Accuracy reports’s new survey, global Buclizine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Buclizine market research.
Key manufacturers engaged in the Buclizine industry include Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma and HUA Shin Chemical Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Buclizine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Buclizine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Buclizine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Stuart Pharmaceuticals
Laboratorios Rocnarf
UCB
Mankind Pharma
Johnson and Johnson
Meider Pharma
Sanofi
MK Pharma
HUA Shin Chemical Pharmaceutical
Peili Pharmaceutical
Pfizer
Sinphar
Al Pharm
Segment by Type
Hospital
Drug Store

Segment by Application


Antiallergic Agent
Histamine H₁-Receptor Antagonist

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Buclizine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Buclizine Market Overview
1.1 Product Overview and Scope of Buclizine
1.2 Buclizine Segment by Type
1.2.1 Global Buclizine Market Value Comparison by Type (2024-2034)
1.2.2 Hospital
1.2.3 Drug Store
1.3 Buclizine Segment by Application
1.3.1 Global Buclizine Market Value by Application: (2024-2034)
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Global Buclizine Market Size Estimates and Forecasts
1.4.1 Global Buclizine Revenue 2018-2034
1.4.2 Global Buclizine Sales 2018-2034
1.4.3 Global Buclizine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Buclizine Market Competition by Manufacturers
2.1 Global Buclizine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Buclizine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Buclizine Average Price by Manufacturers (2018-2024)
2.4 Global Buclizine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Buclizine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buclizine, Product Type & Application
2.7 Buclizine Market Competitive Situation and Trends
2.7.1 Buclizine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Buclizine Players Market Share by Revenue
2.7.3 Global Buclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Buclizine Retrospective Market Scenario by Region
3.1 Global Buclizine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Buclizine Global Buclizine Sales by Region: 2018-2034
3.2.1 Global Buclizine Sales by Region: 2018-2024
3.2.2 Global Buclizine Sales by Region: 2024-2034
3.3 Global Buclizine Global Buclizine Revenue by Region: 2018-2034
3.3.1 Global Buclizine Revenue by Region: 2018-2024
3.3.2 Global Buclizine Revenue by Region: 2024-2034
3.4 North America Buclizine Market Facts & Figures by Country
3.4.1 North America Buclizine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Buclizine Sales by Country (2018-2034)
3.4.3 North America Buclizine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buclizine Market Facts & Figures by Country
3.5.1 Europe Buclizine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Buclizine Sales by Country (2018-2034)
3.5.3 Europe Buclizine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buclizine Market Facts & Figures by Country
3.6.1 Asia Pacific Buclizine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Buclizine Sales by Country (2018-2034)
3.6.3 Asia Pacific Buclizine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Buclizine Market Facts & Figures by Country
3.7.1 Latin America Buclizine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Buclizine Sales by Country (2018-2034)
3.7.3 Latin America Buclizine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buclizine Market Facts & Figures by Country
3.8.1 Middle East and Africa Buclizine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Buclizine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Buclizine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buclizine Sales by Type (2018-2034)
4.1.1 Global Buclizine Sales by Type (2018-2024)
4.1.2 Global Buclizine Sales by Type (2024-2034)
4.1.3 Global Buclizine Sales Market Share by Type (2018-2034)
4.2 Global Buclizine Revenue by Type (2018-2034)
4.2.1 Global Buclizine Revenue by Type (2018-2024)
4.2.2 Global Buclizine Revenue by Type (2024-2034)
4.2.3 Global Buclizine Revenue Market Share by Type (2018-2034)
4.3 Global Buclizine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Buclizine Sales by Application (2018-2034)
5.1.1 Global Buclizine Sales by Application (2018-2024)
5.1.2 Global Buclizine Sales by Application (2024-2034)
5.1.3 Global Buclizine Sales Market Share by Application (2018-2034)
5.2 Global Buclizine Revenue by Application (2018-2034)
5.2.1 Global Buclizine Revenue by Application (2018-2024)
5.2.2 Global Buclizine Revenue by Application (2024-2034)
5.2.3 Global Buclizine Revenue Market Share by Application (2018-2034)
5.3 Global Buclizine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Stuart Pharmaceuticals
6.1.1 Stuart Pharmaceuticals Corporation Information
6.1.2 Stuart Pharmaceuticals Description and Business Overview
6.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Stuart Pharmaceuticals Buclizine Product Portfolio
6.1.5 Stuart Pharmaceuticals Recent Developments/Updates
6.2 Laboratorios Rocnarf
6.2.1 Laboratorios Rocnarf Corporation Information
6.2.2 Laboratorios Rocnarf Description and Business Overview
6.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Laboratorios Rocnarf Buclizine Product Portfolio
6.2.5 Laboratorios Rocnarf Recent Developments/Updates
6.3 UCB
6.3.1 UCB Corporation Information
6.3.2 UCB Description and Business Overview
6.3.3 UCB Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 UCB Buclizine Product Portfolio
6.3.5 UCB Recent Developments/Updates
6.4 Mankind Pharma
6.4.1 Mankind Pharma Corporation Information
6.4.2 Mankind Pharma Description and Business Overview
6.4.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mankind Pharma Buclizine Product Portfolio
6.4.5 Mankind Pharma Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Johnson and Johnson Buclizine Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 Meider Pharma
6.6.1 Meider Pharma Corporation Information
6.6.2 Meider Pharma Description and Business Overview
6.6.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Meider Pharma Buclizine Product Portfolio
6.6.5 Meider Pharma Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sanofi Buclizine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 MK Pharma
6.8.1 MK Pharma Corporation Information
6.8.2 MK Pharma Description and Business Overview
6.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 MK Pharma Buclizine Product Portfolio
6.8.5 MK Pharma Recent Developments/Updates
6.9 HUA Shin Chemical Pharmaceutical
6.9.1 HUA Shin Chemical Pharmaceutical Corporation Information
6.9.2 HUA Shin Chemical Pharmaceutical Description and Business Overview
6.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
6.9.5 HUA Shin Chemical Pharmaceutical Recent Developments/Updates
6.10 Peili Pharmaceutical
6.10.1 Peili Pharmaceutical Corporation Information
6.10.2 Peili Pharmaceutical Description and Business Overview
6.10.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Peili Pharmaceutical Buclizine Product Portfolio
6.10.5 Peili Pharmaceutical Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Buclizine Description and Business Overview
6.11.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Pfizer Buclizine Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sinphar
6.12.1 Sinphar Corporation Information
6.12.2 Sinphar Buclizine Description and Business Overview
6.12.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Sinphar Buclizine Product Portfolio
6.12.5 Sinphar Recent Developments/Updates
6.13 Al Pharm
6.13.1 Al Pharm Corporation Information
6.13.2 Al Pharm Buclizine Description and Business Overview
6.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Al Pharm Buclizine Product Portfolio
6.13.5 Al Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buclizine Industry Chain Analysis
7.2 Buclizine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buclizine Production Mode & Process
7.4 Buclizine Sales and Marketing
7.4.1 Buclizine Sales Channels
7.4.2 Buclizine Distributors
7.5 Buclizine Customers
8 Buclizine Market Dynamics
8.1 Buclizine Industry Trends
8.2 Buclizine Market Drivers
8.3 Buclizine Market Challenges
8.4 Buclizine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Buclizine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Buclizine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Buclizine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Buclizine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Buclizine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Buclizine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Buclizine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Buclizine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Buclizine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Buclizine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Buclizine, Product Type & Application
Table 12. Global Key Manufacturers of Buclizine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Buclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buclizine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Buclizine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Buclizine Sales by Region (2018-2024) & (K Units)
Table 18. Global Buclizine Sales Market Share by Region (2018-2024)
Table 19. Global Buclizine Sales by Region (2024-2034) & (K Units)
Table 20. Global Buclizine Sales Market Share by Region (2024-2034)
Table 21. Global Buclizine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Buclizine Revenue Market Share by Region (2018-2024)
Table 23. Global Buclizine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Buclizine Revenue Market Share by Region (2024-2034)
Table 25. North America Buclizine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Buclizine Sales by Country (2018-2024) & (K Units)
Table 27. North America Buclizine Sales by Country (2024-2034) & (K Units)
Table 28. North America Buclizine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Buclizine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Buclizine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Buclizine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Buclizine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Buclizine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Buclizine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Buclizine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Buclizine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Buclizine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Buclizine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Buclizine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Buclizine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Buclizine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Buclizine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Buclizine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Buclizine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Buclizine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Buclizine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Buclizine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Buclizine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Buclizine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Buclizine Sales (K Units) by Type (2018-2024)
Table 51. Global Buclizine Sales (K Units) by Type (2024-2034)
Table 52. Global Buclizine Sales Market Share by Type (2018-2024)
Table 53. Global Buclizine Sales Market Share by Type (2024-2034)
Table 54. Global Buclizine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Buclizine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Buclizine Revenue Market Share by Type (2018-2024)
Table 57. Global Buclizine Revenue Market Share by Type (2024-2034)
Table 58. Global Buclizine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Buclizine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Buclizine Sales (K Units) by Application (2018-2024)
Table 61. Global Buclizine Sales (K Units) by Application (2024-2034)
Table 62. Global Buclizine Sales Market Share by Application (2018-2024)
Table 63. Global Buclizine Sales Market Share by Application (2024-2034)
Table 64. Global Buclizine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Buclizine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Buclizine Revenue Market Share by Application (2018-2024)
Table 67. Global Buclizine Revenue Market Share by Application (2024-2034)
Table 68. Global Buclizine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Buclizine Price (US$/Unit) by Application (2024-2034)
Table 70. Stuart Pharmaceuticals Corporation Information
Table 71. Stuart Pharmaceuticals Description and Business Overview
Table 72. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Stuart Pharmaceuticals Buclizine Product
Table 74. Stuart Pharmaceuticals Recent Developments/Updates
Table 75. Laboratorios Rocnarf Corporation Information
Table 76. Laboratorios Rocnarf Description and Business Overview
Table 77. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Laboratorios Rocnarf Buclizine Product
Table 79. Laboratorios Rocnarf Recent Developments/Updates
Table 80. UCB Corporation Information
Table 81. UCB Description and Business Overview
Table 82. UCB Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. UCB Buclizine Product
Table 84. UCB Recent Developments/Updates
Table 85. Mankind Pharma Corporation Information
Table 86. Mankind Pharma Description and Business Overview
Table 87. Mankind Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Mankind Pharma Buclizine Product
Table 89. Mankind Pharma Recent Developments/Updates
Table 90. Johnson and Johnson Corporation Information
Table 91. Johnson and Johnson Description and Business Overview
Table 92. Johnson and Johnson Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Johnson and Johnson Buclizine Product
Table 94. Johnson and Johnson Recent Developments/Updates
Table 95. Meider Pharma Corporation Information
Table 96. Meider Pharma Description and Business Overview
Table 97. Meider Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Meider Pharma Buclizine Product
Table 99. Meider Pharma Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Sanofi Buclizine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. MK Pharma Corporation Information
Table 106. MK Pharma Description and Business Overview
Table 107. MK Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. MK Pharma Buclizine Product
Table 109. MK Pharma Recent Developments/Updates
Table 110. HUA Shin Chemical Pharmaceutical Corporation Information
Table 111. HUA Shin Chemical Pharmaceutical Description and Business Overview
Table 112. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. HUA Shin Chemical Pharmaceutical Buclizine Product
Table 114. HUA Shin Chemical Pharmaceutical Recent Developments/Updates
Table 115. Peili Pharmaceutical Corporation Information
Table 116. Peili Pharmaceutical Description and Business Overview
Table 117. Peili Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Peili Pharmaceutical Buclizine Product
Table 119. Peili Pharmaceutical Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Pfizer Buclizine Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Sinphar Corporation Information
Table 126. Sinphar Description and Business Overview
Table 127. Sinphar Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Sinphar Buclizine Product
Table 129. Sinphar Recent Developments/Updates
Table 130. Al Pharm Corporation Information
Table 131. Al Pharm Description and Business Overview
Table 132. Al Pharm Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Al Pharm Buclizine Product
Table 134. Al Pharm Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Buclizine Distributors List
Table 138. Buclizine Customers List
Table 139. Buclizine Market Trends
Table 140. Buclizine Market Drivers
Table 141. Buclizine Market Challenges
Table 142. Buclizine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Buclizine
Figure 2. Global Buclizine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Buclizine Market Share by Type in 2022 & 2034
Figure 4. Hospital Product Picture
Figure 5. Drug Store Product Picture
Figure 6. Global Buclizine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Buclizine Market Share by Application in 2022 & 2034
Figure 8. Antiallergic Agent
Figure 9. Histamine H₁-Receptor Antagonist
Figure 10. Global Buclizine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 11. Global Buclizine Market Size (2018-2034) & (US$ Million)
Figure 12. Global Buclizine Sales (2018-2034) & (K Units)
Figure 13. Global Buclizine Average Price (US$/Unit) & (2018-2034)
Figure 14. Buclizine Report Years Considered
Figure 15. Buclizine Sales Share by Manufacturers in 2022
Figure 16. Global Buclizine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Buclizine Players: Market Share by Revenue in 2022
Figure 18. Buclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Buclizine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 20. North America Buclizine Sales Market Share by Country (2018-2034)
Figure 21. North America Buclizine Revenue Market Share by Country (2018-2034)
Figure 22. United States Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Buclizine Sales Market Share by Country (2018-2034)
Figure 25. Europe Buclizine Revenue Market Share by Country (2018-2034)
Figure 26. Germany Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Buclizine Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Buclizine Revenue Market Share by Region (2018-2034)
Figure 33. China Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Buclizine Sales Market Share by Country (2018-2034)
Figure 43. Latin America Buclizine Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Buclizine Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Buclizine Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Buclizine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Buclizine by Type (2018-2034)
Figure 53. Global Revenue Market Share of Buclizine by Type (2018-2034)
Figure 54. Global Buclizine Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Buclizine by Application (2018-2034)
Figure 56. Global Revenue Market Share of Buclizine by Application (2018-2034)
Figure 57. Global Buclizine Price (US$/Unit) by Application (2018-2034)
Figure 58. Buclizine Value Chain
Figure 59. Buclizine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed